Handa Pharmaceuticals Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	749.77	472.74	726.89	-40.01	-247.67
Depreciation & Amortization	164.13	10.16	12.15	14.82	16.49
Other Amortization	-	0.27	0.3	0.36	18.67
Loss (Gain) From Sale of Assets	-12.84	0.19	-4.61	0	-0.02
Loss (Gain) on Equity Investments	-0.29	1.81	-2.37	-	-
Stock-Based Compensation	16.39	22.39	8.47	0.11	0.26
Other Operating Activities	-21.13	-189.23	51.87	-5.55	-13.62
Change in Accounts Receivable	-762.56	207.08	-226.18	-140.58	13.41
Change in Inventory	39.22	-	-	10.11	-
Change in Accounts Payable	47.04	6.57	8.34	5.1	-8.26
Change in Other Net Operating Assets	23.9	-34.38	93.51	-55.93	41.51
Operating Cash Flow	243.63	497.6	668.36	-211.57	-179.24
Operating Cash Flow Growth	-51.04%	-25.55%	-	-	-
Capital Expenditures	-16.92	-7.77	-0.94	-0.64	-5.58
Sale of Property, Plant & Equipment	-	0	-	0	0.03
Cash Acquisitions	-155.9	-819.63	-	-	-
Divestitures	-	-	-10.97	-	-
Sale (Purchase) of Intangibles	-0.17	-	-	-0.12	-1.57
Investment in Securities	-674.86	431.12	-1,653	30.71	3.98
Other Investing Activities	-	-0.65	-	-0.45	0.23
Investing Cash Flow	-847.84	-396.92	-1,665	29.5	-2.91
Long-Term Debt Repaid	-13.26	-6.07	-7.17	-7.19	-7.77
Total Debt Repaid	-13.26	-6.07	-7.17	-7.19	-7.77
Net Debt Issued (Repaid)	-13.26	-6.07	-7.17	-7.19	-7.77
Issuance of Common Stock	2,102	3.12	1,313	320.83	170.68
Repurchase of Common Stock	-57.88	-56.52	-	-	-
Common Dividends Paid	-236.3	-141.09	-	-	-
Other Financing Activities	-3	-	-	-	-
Financing Cash Flow	1,792	-200.55	1,306	313.65	162.91
Foreign Exchange Rate Adjustments	22.39	30.2	-8.34	-28.97	2.44
Net Cash Flow	1,210	-69.67	301.13	102.6	-16.81
Free Cash Flow	226.72	489.84	667.42	-212.21	-184.82
Free Cash Flow Growth	-53.72%	-26.61%	-	-	-
Free Cash Flow Margin	13.11%	58.97%	60.33%	-107.35%	-632.19%
Free Cash Flow Per Share	1.46	3.47	4.95	-1.69	-1.57
Cash Interest Paid	1.04	0.49	0.22	0.28	0.23
Cash Income Tax Paid	191.19	197.46	7.78	2.42	0.45
Levered Free Cash Flow	289.27	438.42	450.86	-224.91	-74.36
Unlevered Free Cash Flow	290.64	438.73	450.99	-224.74	-74.21
Change in Working Capital	-652.4	179.27	-124.33	-181.31	46.66

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.